Pfizer CEO Albert Bourla said he’s confident the full results from the clinical trials will show that the oral antiviral pill, Paxlovid, reduces hospitalization and death by 89%.
Pfizer CEO Albert Bourla said he’s confident the full results from the clinical trials will show that the oral antiviral pill, Paxlovid, reduces hospitalization and death by 89%.
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!